search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
136 EUTECTIC SYSTEMS In this context, ANDES highlight the potential


of eutectic systems as a versatile platform for next-generation personal care formulations, where stability, efficacy, formulation simplicity, and sustainability are addressed together through system-level design. The following case study on eutectic


hyaluronic acid illustrates how these ANDES principles can be applied in practice to re- engineer a well-established cosmetic active within a structured eutectic liquid environment.


Case study: eutectic hyaluronic acid Hyaluronic acid (HA) is widely recognized for its exceptional water-binding capacity and its role in supporting skin hydration, elasticity, and barrier function. However, its cosmetic performance is constrained by high molecular weight, viscosity limitations, susceptibility to enzymatic degradation, and restricted penetration into deeper skin layers.3 Eutectic hyaluronic acid illustrates how


eutectic design can be applied to a well- established cosmetic active to unlock enhanced performance. By embedding HA into a eutectic matrix, its physicochemical environment is transformed, enabling improved hydration efficacy at significantly reduced active concentrations.


Mechanisms of stability enhancement Eutectic systems can enhance hyaluronic acid stability by forming a structured intermolecular- bond network that limits water activity and reduces enzymatic accessibility. This organized microenvironment hinders hyaluronidase- mediated depolymerization, preserving hyaluronic acid molecular integrity and functional performance over time.4 Reduced free water availability further


suppresses hydrolytic degradation pathways, contributing to prolonged stability during storage and after application.


Dermal delivery and skin interaction Beyond stabilization, eutectic systems influence dermal delivery by modulating the interaction between actives and the stratum corneum. Hydrogen-bond donors and acceptors within the eutectic matrix may transiently interact with skin components, facilitating diffusion without


Parameter


Active concentration in formula


Superficial hydration-mean improvement


Deep hydration – mean improvement


Skin barrier function (TEWL) statistical significance (T0 vs 3 weeks)


Formulation implication Overall delivery efficiency Dermal Delivery and Skin Interaction


Figure 3: Schematic representation of dermal delivery modulation by eutectic systems


disrupting barrier integrity. Unlike aggressive penetration enhancers, eutectic systems rely on reversible, non-disruptive interactions, supporting suitability for sensitive-skin applications.


Clinical, formulation, and sustainability impact Clinical evaluations of eutectic hyaluronic acid formulations have demonstrated superior surface and deep hydration compared to conventional hyaluronic acid, despite using substantially lower active concentrations. Improvements in barrier function, elasticity, and


tolerability have been observed, alongside reduced formulation complexity. From a sustainability perspective, eutectic


systems offer additional advantages. Components are typically biodegradable, derived from renewable feedstocks, and compatible with clean- label standards. Reduced water activity may contribute to intrinsic microbiological robustness, potentially


Conventional ‘free’ hyaluronic acid (Control) Reference level (100%) +49% +6%


Healthy range Significant for hydration parameters


Higher dose required to reach target efficacy


Conventional diffusion-limited behaviour


Eutectic/ANDES-based hyaluronic acid Up to 80% lower active level +68% +9%


Healthy range Significant for hydration parameters


Higher efficacy at reduced active load


Enhanced functional availability via eutectic structuring


Table 1: Comparative cosmetic efficacy and safety of conventional (‘free’) vs eutectic (ANDES-based) hyaluronic acid systems. Clinical test, n=15, female panellists ranged in age from 19 to 66 years old, 3 weeks, PROTOCOLS Nº: 0189-25B-09EMOD1-0244-25-09E


PERSONAL CARE MAGAZINE April 2026


lowering preservative demand. Manufacturing processes are generally low-energy and scalable, supporting broader industrial adoption.


Conclusion Eutectic systems represent a structural advance in cosmetic formulation, offering a new framework for addressing long-standing challenges in active stability, delivery, and formulation efficiency. By incorporating actives into supramolecular


liquid networks, Active Natural Deep Eutectic Systems provide enhanced functional performance while supporting simplified and more sustainable formulation design. The eutectic hyaluronic acid example illustrates how established actives can be re-engineered through eutectic structuring to meet modern performance expectations. Extending these principles to additional


cosmetic actives is an active area of development, underscoring the potential of eutectic systems as a versatile platform for next-generation personal care formulations.


PCM


References 1. Espino M, Fernández MA, Gomez FJV, Silva MF. Natural designer solvents for greening analytical chemistry. Trends Anal Chem. 2016;76:126–136


2. Lorenzetti AS et al. Native Fluorescent Natural Deep Eutectic Solvents for Green Sensing Applications: Curcuminoids in Curcuma longa Powder. ACS Sustain Chem Eng. 2021


3. Zanchetta C et al. Hyaluronic Acid in Topical Applications: The Various Forms and Biological Effects of a Hero Molecule in the Cosmetics Industry. Biomolecules. 2025;15:1656


4. Smith Buarque FS et al. Choline chloride- based deep eutectic solvent as an inhibitor of metalloproteases (collagenase and elastase) in cosmetic formulation. 3 Biotech. 2023;13:219


www.personalcaremagazine.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140  |  Page 141  |  Page 142  |  Page 143  |  Page 144  |  Page 145  |  Page 146  |  Page 147  |  Page 148  |  Page 149  |  Page 150  |  Page 151  |  Page 152